Stay informed about the latest Bardet-Biedl Syndrome research. Save papers to your personal knowledge base and ask questions about your collected research.
Latest Research
Automatically updated with new BBS papers from PubMed
Personal Knowledge Base
Save relevant papers and add your own notes
AI-Powered Q&A
Ask questions and get answers from your saved research
Latest Research
Coats-like exudative vasculopathy in a patient with Bardet-Biedl syndrome.
Kishi E et al.
We report a case of Bardet-Biedl syndrome (BBS) complicated by bilateral Coats-like exudative vasculopathy with exudative retinal detachment and neovascular glaucoma (NVG).
A 10-year-old boy noticed decreased visual acuity and was referred to our clinic. He had a history of retinitis pigmentosa, re...
Mesenchymal drift in ciliopathy iPSC-derived RPE reveals a convergent pathogenic cell state.
Reichert D et al.
Ciliopathies comprise a spectrum of disorders involving mutations in over 150 genes affecting the primary cilium, with retinal degeneration as a prominent feature driven by concomitant developmental and maturation defects in photoreceptors and the retinal pigment epithelium (RPE). Current single-gen...
Diagnosing the canvas: challenging the diagnosis of Prader-Willi syndrome in Eugenia Martínez Vallejo (1674-1699).
Hamiel U, Pinhas-Hamiel O
Eugenia Martínez Vallejo (1674-1699), famously portrayed by Juan Carreño de Miranda at the court of King Carlos II of Spain, has long been considered a historical example of Prader-Willi syndrome (PWS). More than 20 publications have supported this diagnosis based on her severe obesity, fa...
BBS5 as a robust prognostic biomarker in esophageal squamous cell carcinoma: validation in two independent cohorts.
Aoki K et al.
Esophageal squamous cell carcinoma (ESCC) remains a highly lethal malignancy, and reliable biomarkers for predicting metastasis and prognosis are urgently needed. Through comprehensive transcriptomic profiling, we identified Bardet-Biedl syndrome 5 (BBS5) as a potential biomarker of clinical signifi...
Precision Medicine in patients with rare forms of genetic obesity: Necessity for coordinated and structured care.
Clément K et al.
Advances in research enable precision medicine for rare metabolic diseases. The approval of therapies as melanocortin-4 receptor (MC4R) agonists for the treatment of hyperphagia and obesity in monogenic disorders (POMC, PCSK1, and LEPR deficiencies) and Bardet-Biedl syndrome (BBS), affecting fewer t...
Clinical, Genetic, and Endocrine Features of Bardet-Biedl Syndrome in a Pediatric and Adult Cohort.
Hassan D et al.
Bardet-Biedl syndrome (BBS) is a rare autosomal recessive disorder characterized by clinical and genetic heterogeneity. Data on the prevalence of clinical manifestations and comorbidities in BBS, particularly in pediatric patients, are limited. This study aimed to assess the prevalence and various m...
Assessment of cardiometabolic risk using single point insulin sensitivity estimator (SPISE) in pediatric Bardet-Biedl Syndrome: a pilot study.
Kandemir T et al.
Bardet-Biedl syndrome (BBS) carries early cardiometabolic risk, yet pediatric screening is complicated by growth and puberty. The metabolic syndrome (MetS) z-score provides a continuous benchmark for clustered risk. The single-point insulin sensitivity estimator (SPISE), based on body mass index (BM...
Melanocortin-4 Receptor Regulation of Endocrine Axes and Clinical Effects of Setmelanotide.
Hühne T et al.
Bardet-Biedl syndrome (BBS) is a rare ciliopathy characterized by early-onset obesity and multisystem endocrine dysfunction. The melanocortin-4 receptor (MC4R) agonist setmelanotide is approved for hyperphagia-related obesity in BBS, but its endocrine effects remain incompletely understood.
In this...
Monogenic and syndromic obesity in children: Clinical recognition, genetics, and precision management.
Khalil H et al.
Obesity is increasingly being recognized as a heterogeneous condition with strong genetic underpinnings. Monogenic obesity, caused by single-gene mutations, primarily affects the leptin-melanocortin pathway, which regulates hunger and satiety. Mutations in genes, such as LEP, LEPR, POMC, PCSK1, and...
Kidney disease and surveillance testing in children with Bardet-Biedl syndrome: an administrative data study.
AI Summary
Finer G et al.
No abstract available for this paper.
Bardet-Biedl syndrome in a Chinese patient with a novel homozygous BBS5 variant from paternal uniparental disomy.
Liu J et al.
Bardet-Biedl syndrome (BBS) is a rare, autosomal recessive genetic disorder with multi-systemic symptoms, including polydactyly, obesity, renal anomalies, retinal dystrophy, and cognitive impairment. Our study reported a previously unreported BBS5 homozygous variant in a Chinese patient with BBS fro...
Research Progress on the Pathogenesis and Diagnostic and Therapeutic Potential of Ciliopathies Regulated by IFT172.
Chen D et al.
IFT172 is a core component of intraflagellar transport complex B (IFT-B), and pathogenic IFT172 variants disrupt ciliary transport, receptor localization, and tissue-specific signaling. This review summarizes evidence linking IFT172 dysfunction to neurological, retinal, skeletal, renal, and syndromi...